A new CDC report has revealed that clinical cases of Candida auris, an emerging fungus considered an urgent threat, nearly doubled in 2021. The report showed a tripling of cases resistant to echinocandins, the first-line treatment for Candida auris infections, and the director of the National Reference Centre for Invasive Fungus Infections has called the rise in cases "alarming". The CDC is urging health care providers to take steps to prevent the spread of C. auris, such as using proper infection control practices and following the CDC's recommendations for diagnosis and management.
